Ordopidine

CAS No. 871351-60-9

Ordopidine( —— )

Catalog No. M34675 CAS No. 871351-60-9

Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 216 Get Quote
5MG 333 Get Quote
10MG 504 Get Quote
25MG 790 Get Quote
50MG 1086 Get Quote
100MG 1431 Get Quote
500MG 2871 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ordopidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity.
  • Description
    Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity. Ordopidine acts as a dopamine D2 receptor antagonist in vitro and, despite its low affinity, its specific state-dependent behavioral effect characteristics are not generally shared by D2 receptor antagonists.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    871351-60-9
  • Formula Weight
    285.38
  • Molecular Formula
    C14H20FNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=C(C=CC=C1S(C)(=O)=O)C2CCN(CC)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ro 10-5824 dihydroch...

    Ro 10-5824 dihydrochloride is a selective agonist of dopamine D4 receptor partial, (Ki of 5.2 nM).

  • NMI 8739

    NMI 8739 is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.

  • Trimethobenzamide hy...

    Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.